Releasing
DEC is your partner in the development and manufacture of moulded and extruded products to release the potential of your potent drug delivery device.
Make
Perfect.
As innovative biotech businesses pioneer new drug delivery solutions, they require excellence in both development support and manufacturing services to realise the potential that their product represents.
DEC is a CDMO expert in both the development and manufacture of controlled release moulded and extruded potent drug delivery products.
With over 40 years of experience in hormone-releasing implant development and manufacturing, we support our partners from clinical phase to commercialisation.
From co-design and development, with quality systems and analytics through to product and GMP manufacturing.
Throughout, our focus is not only the release of the drugs and the release of your product, but on releasing the potential of your vision.
This requires more than the world-class capabilities to make your product, it requires the commitment to making it perfectly and to making it at scale.
Make. Make Perfect. Repeat.™
Our Technologies
Product
Technologies
Product
Technologies
DEC’s proprietary manufacturing technologies allow scalable manufacture of market-leading transdermal, subdermal and intracavitary silicone and polymeric devices delivering potent, slow-release actives.
Process
Technologies
Process
Technologies
DEC’s proprietary CDMO technologies leverage a combination of processes including injection moulding, extrusion and co-extrusion methods to enable scalable manufacture of slow-release actives.
Product
Technologies
Product
Technologies
DEC’s proprietary manufacturing technologies allow scalable manufacture of market-leading transdermal, subdermal and intracavitary silicone and polymeric devices delivering potent, slow-release actives.
